Safety and tolerability of tegaserod in irritable bowel syndrome management.
D002986:Clinical Trials as Topic; D004347:Drug Interactions; D005765:Gastrointestinal Agents / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000494:pharmacology; D006801:Humans; D007211:Indoles / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000494:pharmacology; D043183:Irritable Bowel Syndrome / Q000188:drug therapy* / Q000453:epidemiology; D010353:Patient Education as Topic; D017366:Serotonin Receptor Agonists / Q000009:adverse effects* / Q000627:therapeutic use; D014481:United States / Q000453:epidemiology
D005765:Gastrointestinal Agents; D007211:Indoles; D017366:Serotonin Receptor Agonists; C105050:tegaserod